Patients entered and enrolled | 40 |
Median age, years (range) | 61.5 (30–76) |
WHO performance status, n (%) | |
0 | 18 (45.0) |
1 | 16 (40.0) |
2 | 6 (15.0) |
Histology, n (%) | |
Breast | 1 (2.5) |
Ductal breast | 31 (77.5) |
Lobular breast | 8 (20.0) |
Number of metastatic sites, n (%) | |
1 | 12 (30.0) |
2 | 21 (52.5) |
3 | 4 (10.0) |
≥4 | 3 (7.5) |
Metastatic sites of diseasea, n (%) | |
Visceral | 35 (87.5) |
Liver | 26 (65.0) |
Lung (including pleura) | 17 (42.5) |
Nonvisceral only | 5 (12.5) |
Menopausal status, n (%) | |
Pre-menopausal | 20 (50.0) |
Menopausal | 8 (20.0) |
Post-menopausal | 10 (25.0) |
Unknown | 2 (5.0) |
Estrogen/progesterone receptors, n (%) | |
Positive | 23 (57.5) |
Negative | 12 (30.0) |
Unknown | 5 (12.5) |